Produktname:(4-Bromo-3-methylisoxazol-5-yl)methyl acetate
IUPAC Name:(4-bromo-3-methyl-1,2-oxazol-5-yl)methyl acetate
- CAS：1380089-33-7
- Molekulare Formel：C7H8BrNO3
- Reinheit：97%
- Katalognummer：CM249144
- Molekulargewicht：234.05
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1380089-33-7
- Molekulare Formel:C7H8BrNO3
- Schmelzpunkt:-
- SMILES-Code:CC(OCC1=C(Br)C(C)=NO1)=O
- Dichte:
- Katalognummer:CM249144
- Molekulargewicht:234.05
- Siedepunkt:
- Mdl-Nr.:MFCD24387374
- Lagerung:Store at room temperature.
Category Infos
- Isoxazoles
- Isoxazole is a liquid heterocyclic compound C3H3NO isomeric with oxazole and having a penetrating odor like that of pyridine. Isoxazoles belong to an important class of five-membered aromatic heterocycles containing two electronegative heteroatoms, nitrogen and oxygen, in a 1,2-relationship and three regular sp2 carbon atoms. These molecules are found to be key components in various synthetic products in daily use and also present as a pharmacophore essential for biological activity in many drugs and bioactive natural products. In addition, isoxazoles have demonstrated their ability to exhibit hydrogen bond donor/acceptor interactions with a variety of enzymes and receptors.
Column Infos
- Pelabresib
- MorphoSys’ phase 3 study of Pelabresib in myelofibrosis demonstrates statistically significant improvement in spleen volume reduction and strong positive trend in symptom reduction.
Pelabresib (CPI-0610) is an investigational selective small molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes in cancer. MorphoSys intends to submit for approval in the U.S. and Europe in mid-2024.
Suche 
+86 21 5895 0110 
